Clinical trial
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
NCT05795595
Study timeline
Study start (actual)2023-03-13Date precision: day
Registry last updated2025-11-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Clear Cell Renal Cell Carcinomaunresolved
Cervical Carcinomaunresolved
Esophageal Carcinomaunresolved
Pancreatic Adenocarcinomaunresolved
Malignant Pleural Mesotheliomaunresolved
Interventions
CTX131BIOLOGICAL
Sponsors & collaborators
CRISPR Therapeutics AGlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05795595 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.